Dergiler / Journal of Experimental and Clinical Medicine / 2026 / Volume: 38 Issue: 3

Coexistence of gastrointestinal stromal tumor of the stomach and small bowel adenocarcinoma: A case report

Talat Ayyıldız(Ondokuz Mayis University, School of Medicine, Deparment of Gastroenterology, Samsun)0000-0003-1075-7499
İbrahim Gören(Ondokuz Mayis University, School of Medicine, Deparment of Gastroenterology, Samsun)0000-0002-9985-1811
Beytullah Yıldırım(Ondokuz Mayis University, School of Medicine, Deparment of Gastroenterology, Samsun)0000-0003-1457-5721
Kağan Karabulut(Ondokuz Mayis University, School of Medicine, Deparment of General Surgery, Samsun)0000-0003-4723-5360
Filiz Karagöz(Ondokuz Mayis University, School of Medicine,Department of Pathology, Samsun)0000-0001-6621-3920
Murat Danacı(Ondokuz Mayis University, School of Medicine,Department of Radiology, Samsun)0000-0001-7785-6139
Ahmet Bektaş(Ondokuz Mayis University, School of Medicine, Department of Gastroenterology, Samsun)0000-0001-7026-9353
Kenan Erzurumlu(Ondokuz Mayis University, School of Medicine, Department of General Surgery, Samsun)
Sayfa
—
Yayın Tarihi
2021-05-01
DOI
—
🏛️Bu makalenin bibliyografik verileri ve tam metin bağlantısı DergiPark üzerinden sağlanmıştır.
DergiPark Kaydı ↗
✨

Yapay Zeka Hızlı Bakış & Çıkarımlar

AI Insight
⚡ TL;DR(1 Cümlede Hızlı Çıkarım)

The prominent characteristics of our case include its antral localisation, male sex, absence of mitosis and incidental diagnosis.

📌 3 Maddede Bu Makale

🎯
Amaç & Hipotez:The coexistence of gastrointestinal tumors (GIST’s) with other several primary malignant neoplasms has been demonstrated.
📊
Temel Bulgular & Veri:Computed tomography scan showed a 13 mm mass located at the gastric antrum and another mass lesion partially occluding the jejunum.
💡
Sonuç & Katkı:The prominent characteristics of our case include its antral localisation, male sex, absence of mitosis and incidental diagnosis.
🔬Tür:Case Report
📍Kapsam:Genişletilmiş Akademik Örneklem
⚙️Değişkenler:GIST · Small bowel adenocarcinoma · Gastric tumor

Abstract

The coexistence of gastrointestinal tumors (GIST’s) with other several primary malignant neoplasms has been demonstrated. However, there is no study that reported simultaneous occurrence of primary small bowel adenocarcinoma (SBA) and a GIST located in the stomach. Here, we report the first case of SBA and a synchronous gastric GIST. Surgical resection and clinicopathological characterization were performed for the masses identified through endoscopic and radiologic studies. Computed tomography scan showed a 13 mm mass located at the gastric antrum and another mass lesion partially occluding the jejunum. A biopsy specimen was obtained from the mass at the proximal jejunum by enteroscopy. The tumor was reported as adenocarcinoma. The patient was operated by the general surgery team. The features of the submucosal lesion resected from the antrum were consistent with a diagnosis of a GIST which contained spindle cells and showed positive staining with CD-117 and CD-34. Mitosis was not observed and Ki67 index was below 10%. This is the first case of coexistence of GIST of the stomach and a SBA to be reported in English-language literature. The prominent characteristics of our case include its antral localisation, male sex, absence of mitosis and incidental diagnosis.

🔖

Bu Makaleye Atıf Yap

Ayyıldız, T., Gören, İ., Yıldırım, B., Karabulut, K., Karagöz, F., Danacı, M., Bektaş, A., Erzurumlu, K. (2021). Coexistence of gastrointestinal stromal tumor of the stomach and small bowel adenocarcinoma: A case report. Journal of Experimental and Clinical Medicine, Volume: 38 Issue: 3. https://ajindex.com/articles/1423270

📄 Tam Metin PDF Okuyucu

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (19)

  1. Agaimy, A., Wünsch, P. H., Sobin, L. H., Lasota, J., Miettinen, M., 2006. Occurrence of other malignancies in patients with gastrointestinal stromal tumors. Semin. Diagn. Pathol. 23, 120–129.
  2. Bilimoria, K. Y., Bentrem, D. J., Wayne, J. D., Ko, C. Y., Bennett, C. L., Talamonti, M. S., 2009. Small bowel cancer in the United States: changes in epidemiology, treatment, and survival over the last 20 years. Ann. Surg. 249, 63–71.
  3. Bümming, P., Ahlman, H., Andersson, J., Meis-Kindblom, J. M., Kindblom, L. G., Nilsson, B., 2006. Population-based study of the diagnosis and treatment of gastrointestinal stromal tumours. Br. J. Sur. 93, 836–843.
  4. Caterino, S., Lorenzon, L., Petrucciani, N., Iannicelli, E., Pilozzi, E., Romiti, A., Cavallini, M., & Ziparo, V., 2011. Gastrointestinal stromal tumors: correlation between symptoms at presentation, tumor location and prognostic factors in 47 consecutive patients. World. J. Surg. Oncol. 9, 13
  5. Corless, C. L., Barnett, C. M., Heinrich, M. C., 2011. Gastrointestinal stromal tumours: origin and molecular oncology. Nat. Rev. Cancer. 11, 865–878.
  6. Dasanu, C. A., Mesologites, T., Trikudanathan, G., 2011. Synchronous tumors: adenosquamous carcinoma of pancreas and GIST of stomach. J. Gastrointest. Cancer. 42, 186–189.
  7. Fletcher, C. D., Berman, J. J., Corless, C., Gorstein, F., Lasota, J., Longley, B. J., Miettinen, M., O'Leary, T. J., Remotti, H., Rubin, B. P., Shmookler, B., Sobin, L. H., Weiss, S. W., 2002. Diagnosis of gastrointestinal stromal tumors: A consensus approach. Hum. Pathol. 33, 459–465
  8. Gill, S. S., Heuman, D. M., Mihas, A. A., 2001. Small intestinal neoplasms. J. Clin. Gastroenterol. 33, 267–282.
  9. Gonçalves, R., Linhares, E., Albagli, R., Valadão, M., Vilhena, B., Romano, S., Ferreira, C. G., 2010. Occurrence of other tumors in patients with GIST. Surg. Oncol. 19, e140–e143.
  10. Hohenberger, P., Ronellenfitsch, U., Oladeji, O., Pink, D., Ströbel, P., Wardelmann, E., Reichardt, P., 2010. Pattern of recurrence in patients with ruptured primary gastrointestinal stromal tumour. Br. J.Surg. 97, 1854–1859
  11. Joensuu, H., Vehtari, A., Riihimäki, J., Nishida, T., Steigen, S. E., Brabec, P., Plank, L., Nilsson, B., Cirilli, C., Braconi, C., Bordoni, A., Magnusson, M. K., Linke, Z., Sufliarsky, J., Federico, M., Jonasson, J. G., Dei Tos, A. P., Rutkowski, P., 2012. Risk of recurrence of gastrointestinal stromal tumour after surgery: an analysis of pooled population-based cohorts. Lancet Oncol. 13, 265–274.
  12. Karahan, N., Başpinar, Ş., Bozkurt, K. K., Devrım, T., Kapucuoğlu, F. N., 2013. Nörofibromatozis Tip-1'li Hastada Multipl Gastrointestinal Stromal Tümör ve Midede Taşlı Yüzük Hücreli Karsinom Birlikteliği: Olgu Sunumu [Coexistence of multiple gastrointestinal stromal tumors and signet ring cell carcinoma of stomach in a patient with neurofibromatosis type-1: case report]. Turk. Patoloji. Derg. 29, 64–68.
  13. Kindblom, L. G., Remotti, H. E., Aldenborg, F., Meis-Kindblom, J. M., 1998. Gastrointestinal pacemaker cell tumor (GIPACT): gastrointestinal stromal tumors show phenotypic characteristics of the interstitial cells of Cajal. Am. J. Pathol.152, 1259–1269.
  14. Maiorana, A., Fante, R., Maria Cesinaro, A., Adriana Fano, R., 2000. Synchronous occurrence of epithelial and stromal tumors in the stomach: a report of 6 cases. Pathol. Lab. Med. 124, 682–686.
  15. Medeiros, F., Corless, C. L., Duensing, A., Hornick, J. L., Oliveira, A. M., Heinrich, M. C., Fletcher, J. A., Fletcher, C. D., 2004. KIT-negative gastrointestinal stromal tumors: proof of concept and therapeutic implications. Am. J. Surg. Pathol. 28, 889–894.
  16. Mucciarini, C., Rossi, G., Bertolini, F., Valli, R., Cirilli, C., Rashid, I., Marcheselli, L., Luppi, G., Federico, M., 2007. Incidence and clinicopathologic features of gastrointestinal stromal tumors. A population-based study. BMC. Cancer. 7, 230.
  17. Sarlomo-Rikala, M., Kovatich, A. J., Barusevicius, A., Miettinen, M., 1998. CD117: a sensitive marker for gastrointestinal stromal tumors that is more specific than CD34. Mod. Pathol. 11, 728–734.
  18. Talamonti, M. S., Goetz, L. H., Rao, S., Joehl, R. J., 2002. Primary cancers of the small bowel: analysis of prognostic factors and results of surgical management. Arch. Surg. 137, 564–571.
  19. West, R. B., Corless, C. L., Chen, X., Rubin, B. P., Subramanian, S., Montgomery, K., Zhu, S., Ball, C. A., Nielsen, T. O., Patel, R., Goldblum, J. R., Brown, P. O., Heinrich, M. C., van de Rijn, M., 2004. The novel marker, DOG1, is expressed ubiquitously in gastrointestinal stromal tumors irrespective of KIT or PDGFRA mutation status. Am. J. Pathol. 165, 107–113.